These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle. Ramirez-Correa GA; Ma J; Slawson C; Zeidan Q; Lugo-Fagundo NS; Xu M; Shen X; Gao WD; Caceres V; Chakir K; DeVine L; Cole RN; Marchionni L; Paolocci N; Hart GW; Murphy AM Diabetes; 2015 Oct; 64(10):3573-87. PubMed ID: 26109417 [TBL] [Abstract][Full Text] [Related]
4. Discovery and confirmation of O-GlcNAcylated proteins in rat liver mitochondria by combination of mass spectrometry and immunological methods. Cao W; Cao J; Huang J; Yao J; Yan G; Xu H; Yang P PLoS One; 2013; 8(10):e76399. PubMed ID: 24098488 [TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts. Yu P; Hu L; Xie J; Chen S; Huang L; Xu Z; Liu X; Zhou Q; Yuan P; Yan X; Jin J; Shen Y; Zhu W; Fu L; Chen Q; Yu J; Hu J; Cao Q; Wan R; Hong K Int J Cardiol; 2018 Jun; 260():74-81. PubMed ID: 29530619 [TBL] [Abstract][Full Text] [Related]
6. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. Hu Y; Suarez J; Fricovsky E; Wang H; Scott BT; Trauger SA; Han W; Hu Y; Oyeleye MO; Dillmann WH J Biol Chem; 2009 Jan; 284(1):547-555. PubMed ID: 19004814 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Protein O-GlcNAcylation by Mass Spectrometry. Ma J; Hart GW Curr Protoc Protein Sci; 2017 Feb; 87():24.10.1-24.10.16. PubMed ID: 28150883 [TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation of 8-Oxoguanine DNA Glycosylase (Ogg1) Impairs Oxidative Mitochondrial DNA Lesion Repair in Diabetic Hearts. Cividini F; Scott BT; Dai A; Han W; Suarez J; Diaz-Juarez J; Diemer T; Casteel DE; Dillmann WH J Biol Chem; 2016 Dec; 291(51):26515-26528. PubMed ID: 27816939 [TBL] [Abstract][Full Text] [Related]
10. Protein O-GlcNAcylation in diabetes and diabetic complications. Ma J; Hart GW Expert Rev Proteomics; 2013 Aug; 10(4):365-80. PubMed ID: 23992419 [TBL] [Abstract][Full Text] [Related]
11. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Wang Z; Pandey A; Hart GW Mol Cell Proteomics; 2007 Aug; 6(8):1365-79. PubMed ID: 17507370 [TBL] [Abstract][Full Text] [Related]
12. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531 [TBL] [Abstract][Full Text] [Related]
13. Synapsin-1 and tau reciprocal O-GlcNAcylation and phosphorylation sites in mouse brain synaptosomes. Kang MJ; Kim C; Jeong H; Cho BK; Ryou AL; Hwang D; Mook-Jung I; Yi EC Exp Mol Med; 2013 Jun; 45(6):e29. PubMed ID: 23807304 [TBL] [Abstract][Full Text] [Related]
14. Detection and identification of O-GlcNAcylated proteins by proteomic approaches. Vercoutter-Edouart AS; El Yazidi-Belkoura I; Guinez C; Baldini S; Leturcq M; Mortuaire M; Mir AM; Steenackers A; Dehennaut V; Pierce A; Lefebvre T Proteomics; 2015 Mar; 15(5-6):1039-50. PubMed ID: 25429863 [TBL] [Abstract][Full Text] [Related]
15. Regulation of mitochondrial network homeostasis by O-GlcNAcylation. Xue Q; Yan R; Ji S; Yu S Mitochondrion; 2022 Jul; 65():45-55. PubMed ID: 35513218 [TBL] [Abstract][Full Text] [Related]
16. Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose. Gu Y; Ande SR; Mishra S Arch Biochem Biophys; 2011 Jan; 505(1):98-104. PubMed ID: 20887712 [TBL] [Abstract][Full Text] [Related]
17. Dierschke SK; Miller WP; Favate JS; Shah P; Imamura Kawasawa Y; Salzberg AC; Kimball SR; Jefferson LS; Dennis MD J Biol Chem; 2019 Apr; 294(14):5508-5520. PubMed ID: 30733333 [TBL] [Abstract][Full Text] [Related]
18. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Copeland RJ; Bullen JW; Hart GW Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E17-28. PubMed ID: 18445751 [TBL] [Abstract][Full Text] [Related]
19. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy. Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430 [TBL] [Abstract][Full Text] [Related]
20. New insights: A role for O-GlcNAcylation in diabetic complications. Peterson SB; Hart GW Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]